424 related articles for article (PubMed ID: 25126087)
21. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
22. A Review of Podocyte Biology.
Garg P
Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
[TBL] [Abstract][Full Text] [Related]
23. Lipid mediators of insulin signaling in diabetic kidney disease.
Mitrofanova A; Sosa MA; Fornoni A
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1241-F1252. PubMed ID: 31545927
[TBL] [Abstract][Full Text] [Related]
24. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
25. Sphingolipid signaling in renal fibrosis.
Huwiler A; Pfeilschifter J
Matrix Biol; 2018 Aug; 68-69():230-247. PubMed ID: 29343457
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins.
Hammad SM; Twal WO; Arif E; Semler AJ; Klein RL; Nihalani D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32045989
[TBL] [Abstract][Full Text] [Related]
27. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
28. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
29. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
Chang JW; Pardo V; Sageshima J; Chen L; Tsai HL; Reiser J; Wei C; Ciancio G; Burke GW; Fornoni A
Transplantation; 2012 Jun; 93(12):1238-44. PubMed ID: 22499148
[TBL] [Abstract][Full Text] [Related]
30. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
31. Implications of Sphingolipid Metabolites in Kidney Diseases.
Mallela SK; Merscher S; Fornoni A
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457062
[TBL] [Abstract][Full Text] [Related]
32. Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.
Liu J; Wang W
Front Med; 2017 Sep; 11(3):333-339. PubMed ID: 28776307
[TBL] [Abstract][Full Text] [Related]
33. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
34. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
35. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
Campbell KN; Tumlin JA
Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
[TBL] [Abstract][Full Text] [Related]
36. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
37. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
[TBL] [Abstract][Full Text] [Related]
38. Translational Aspects of Sphingolipid Metabolism in Renal Disorders.
Abou Daher A; El Jalkh T; Eid AA; Fornoni A; Marples B; Zeidan YH
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186855
[TBL] [Abstract][Full Text] [Related]
39. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
40. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
